Clinical-stage biotech possibly nearing phase I completion

Nascent Biotech is reportedly closing in on phase I trial completion. I am interested to see if it pulls back and how it interacts with the moving averages.

www.nascentbiotech.c...static-brain-cancer/

Komentarz:

As you can see, the move went higher briefly and eventually landed right around where I started. I made this a while back and had taken all the profit. It was a stage 1 trial so just potential was needed. It is easier to track a stage 1 through the trials and likely get a rise in price. But this is long since over and I do am not recommending the stock by any means. If you do see this, then always read as much as you can about the company's current work.